(MONEY Magazine) – When you screen the stock market for giant companies with strong finances and superior total-return prospects, you get a list of fewer than 200. I've winnowed that to 70 blue-chip growth stocks. All are promising, but not all are equally good values at any given moment. I've recently removed MBNA from the list because Bank of America is acquiring it. I've also dropped Tribune, which is suffering from tax and management problems as well as weak advertising spending. In their places, I've added CVS, the largest drug-retailing chain, which is cheaper than its rival Walgreen, and Danaher, a conglomerate with businesses in niche markets like measuring equipment, leak detectors and motion sensors.

NOTES: As of Oct. 28. P/E ratios are based on projected 2006 earnings. Earnings growth is compound annual rate projected for five years by analysts covering the stock. SOURCE: Thomson/Baseline.